Lineage Point Capital LP Makes New Investment in GP-Act III Acquisition Corp. $GPAT

Lineage Point Capital LP bought a new position in GP-Act III Acquisition Corp. (NASDAQ:GPAT) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 65,000 shares of the company’s stock, valued at approximately $695,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Verition Fund Management LLC lifted its stake in shares of GP-Act III Acquisition by 0.7% during the 4th quarter. Verition Fund Management LLC now owns 229,124 shares of the company’s stock valued at $2,452,000 after buying an additional 1,500 shares in the last quarter. Cannon Global Investment Management LLC grew its stake in GP-Act III Acquisition by 38.1% in the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock valued at $155,000 after buying an additional 4,000 shares in the last quarter. Longfellow Investment Management Co. LLC purchased a new position in GP-Act III Acquisition in the 3rd quarter valued at approximately $83,000. Bank of America Corp DE bought a new stake in GP-Act III Acquisition during the 3rd quarter valued at $85,000. Finally, Clear Street Group Inc. bought a new stake in GP-Act III Acquisition during the 3rd quarter valued at $109,000.

GP-Act III Acquisition Price Performance

Shares of GP-Act III Acquisition stock opened at $10.88 on Friday. The company’s 50-day moving average price is $10.88 and its 200-day moving average price is $10.79. GP-Act III Acquisition Corp. has a 12-month low of $10.50 and a 12-month high of $12.00.

GP-Act III Acquisition (NASDAQ:GPAT) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, GP-Act III Acquisition currently has an average rating of “Sell”.

GP-Act III Acquisition Profile

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.